Table 1.

Clinical trials involving remotely triggered NPs for cancer cell death. Adapted from Ref. [208]

Name (company)	NP type	Stimulus	Disease	Clinical trial number and status
NBTXR3 PEP503 (Nanobiotix)	Hafnium oxide NPs	Radiation therapy	Solid primary tumors or metastasis	NCT01433068: completed NCT01946867: unknown NCT02901483: recruiting NCT02721056: unknown NCT02805894: recruiting NCT03589339: recruiting NCT02379845: unknown NCT02465593: recruiting NCT04484909: recruiting NCT04505267: not yet recruiting
AuroLase (nanospectra biosciences)	PEG-coated silica gold nanoshells	Near-infrared light	Solid primary and/or metastatic tumors	NCT01679470: terminated NCT02680535: active, not recruiting NCT00848042: completed NCT04240639: recruiting
Magnablate	Iron oxide NPs	Magnetic field	Prostate cancer	NCT02033447: completed